LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Emergent BioSolutions (NYSE: EBS)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NYSE EBS Emergent BioSolutions
LINDAHL RICHARD S / officer: EVP, Chief Financial Officer
10/15/2025
Sell
$9.60
4,995
$48K
291,497
NYSE EBS Emergent BioSolutions
Glessner Coleen / officer: EVP, Quality & Ethics, and CPL
10/07/2025
Sell
$10.00
30,608
$306K
144,319